Ragupathy Madiyalakan

Induction of CA125-Specific B and T Cell Responses in Patients Injected with MAb-B43.13—Evidence for Antibody-Mediated Antigen-Processing and Presentation of CA125 in Vivo

A.A. Noujaim, Birgit C. Schultes, Richard P. Baum et al. · Cancer Biotherapy and Radiopharmaceuticals · 2001 · 110 citations

Immunocytochemical Technique, T Cell Responses, Immunology +24

Anti-idiotype induction therapy: anti-CA125 antibodies (Ab 3 ) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab 1 )

Birgit C. Schultes, Richard P. Baum, A. Niesen et al. · Cancer Immunology Immunotherapy · 1998 · 91 citations · Full text

Medicine, Immunology, Immune Checkpoint Inhibitor +8

Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum

Shin Yazawa, Ragupathy Madiyalakan, Khushi L. Matta et al. · Cancer · 1988 · 61 citations

Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer

Divya Thomas, Satish Sagar, Xiang Liu et al. · Molecular Therapy · 2020 · 55 citations · Full text

Antiidiotype Induction Therapy: Evidence for the Induction of Immune Response through the Idiotype Network in Patients with Ovarian Cancer after Administration of Anti-CA 125 Murine Monoclonal Antibody B43.13

Ragupathy Madiyalakan, T.R. Sykes, S. Dharampaul et al. · Hybridoma · 1995 · 40 citations